Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-β- catenin signaling axis.
Valverde A, Peñarando J, Cañas A, López-Sánchez LM, Conde F, Guil-Luna S, Hernández V, Villar C, Morales-Estévez C, de la Haba-Rodríguez J, Aranda E, Rodríguez-Ariza A. Valverde A, et al. Among authors: villar c. Oncotarget. 2017 Mar 28;8(13):21754-21769. doi: 10.18632/oncotarget.15567. Oncotarget. 2017. PMID: 28423516 Free PMC article.
A role for endothelial nitric oxide synthase in intestinal stem cell proliferation and mesenchymal colorectal cancer.
Peñarando J, López-Sánchez LM, Mena R, Guil-Luna S, Conde F, Hernández V, Toledano M, Gudiño V, Raponi M, Billard C, Villar C, Díaz C, Gómez-Barbadillo J, De la Haba-Rodríguez J, Myant K, Aranda E, Rodríguez-Ariza A. Peñarando J, et al. Among authors: villar c. BMC Biol. 2018 Jan 10;16(1):3. doi: 10.1186/s12915-017-0472-5. BMC Biol. 2018. PMID: 29329541 Free PMC article.
HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.
Arjona-Sánchez A, Barrios P, Boldo-Roda E, Camps B, Carrasco-Campos J, Concepción Martín V, García-Fadrique A, Gutiérrez-Calvo A, Morales R, Ortega-Pérez G, Pérez-Viejo E, Prada-Villaverde A, Torres-Melero J, Vicente E, Villarejo-Campos P, Sánchez-Hidalgo JM, Casado-Adam A, García-Martin R, Medina M, Caro T, Villar C, Aranda E, Cano-Osuna MT, Díaz-López C, Torres-Tordera E, Briceño-Delgado FJ, Rufián-Peña S. Arjona-Sánchez A, et al. Among authors: villar c. BMC Cancer. 2018 Feb 13;18(1):183. doi: 10.1186/s12885-018-4096-0. BMC Cancer. 2018. PMID: 29439668 Free PMC article. Clinical Trial.
SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours.
López-Sánchez LM, Jiménez-Izquierdo R, Peñarando J, Mena R, Guil-Luna S, Toledano M, Conde F, Villar C, Díaz C, Ortea I, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. López-Sánchez LM, et al. Among authors: villar c. J Cell Mol Med. 2019 Dec;23(12):8219-8232. doi: 10.1111/jcmm.14693. Epub 2019 Sep 27. J Cell Mol Med. 2019. PMID: 31560832 Free PMC article.
Association of Tumor Budding With Immune Evasion Pathways in Primary Colorectal Cancer and Patient-Derived Xenografts.
Guil-Luna S, Mena R, Navarrete-Sirvent C, López-Sánchez LM, Khouadri K, Toledano-Fonseca M, Mantrana A, Guler I, Villar C, Díaz C, Medina-Fernández FJ, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. Guil-Luna S, et al. Among authors: villar c. Front Med (Lausanne). 2020 Jul 3;7:264. doi: 10.3389/fmed.2020.00264. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32719800 Free PMC article.
Metabolic shift underlies tumor progression and immune evasion in S-nitrosoglutathione reductase-deficient cancer.
Mena-Osuna R, Mantrana A, Guil-Luna S, Sánchez-Montero MT, Navarrete-Sirvent C, Morales-Ruiz T, Rivas-Crespo A, Toledano-Fonseca M, García-Ortíz MV, García-Jurado G, Gómez-España MA, González-Fernández R, Villar C, Medina-Fernández FJ, Villalba JM, Aranda E, Rodríguez-Ariza A. Mena-Osuna R, et al. Among authors: villar c. J Pathol. 2023 Jul;260(3):261-275. doi: 10.1002/path.6080. Epub 2023 Apr 5. J Pathol. 2023. PMID: 37017456
Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial.
Arjona-Sánchez A, Espinosa-Redondo E, Gutiérrez-Calvo A, Segura-Sampedro JJ, Pérez-Viejo E, Concepción-Martín V, Sánchez-García S, García-Fadrique A, Prieto-Nieto I, Barrios-Sanchez P, Torres-Melero J, Ramírez Faraco M, Prada-Villaverde A, Carrasco-Campos J, Artiles-Armas M, Villarejo-Campos P, Ortega-Pérez G, Boldo-Roda E, Sánchez-Hidalgo JM, Casado-Adam A, Rodríguez-Ortiz L, Aranda E, Cano-Osuna MT, Díaz-López C, Romero-Ruiz A, Briceño-Delgado J, Rufián-Peña S; Grupo Español de Carcinomatosis Peritoneal. Arjona-Sánchez A, et al. JAMA Surg. 2023 Jul 1;158(7):683-691. doi: 10.1001/jamasurg.2023.0662. JAMA Surg. 2023. PMID: 37099280 Free PMC article.
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Guil-Luna S, Rivas-Crespo A, Navarrete-Sirvent C, Mantrana A, Pera A, Mena-Osuna R, Toledano-Fonseca M, García-Ortíz MV, Villar C, Sánchez-Montero MT, Krueger J, Medina-Fernández FJ, De La Haba-Rodríguez J, Gómez-España A, Aranda E, Rudd CE, Rodríguez-Ariza A. Guil-Luna S, et al. Among authors: villar c. Biomed Pharmacother. 2023 Nov;167:115592. doi: 10.1016/j.biopha.2023.115592. Epub 2023 Sep 29. Biomed Pharmacother. 2023. PMID: 37778272 Free article.
185 results